Indaptus Therapeutics, Inc. (INDP) KPIs and segments

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$3.17+0.02 (+0.63%)

Close on Nov 13, 2026Market cap $422.38MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Indaptus Therapeutics's business

Coming soon

This tab will track the numbers specific to Indaptus Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?